Artificial Intelligence and Radiomics to Predict Hepatocellular Carcinoma Risk in Cirrhosis Patients
Summary
The National Institutes of Health, through the National Institute of Diabetes and Digestive and Kidney Diseases, is seeking funding to acquire clinical cohorts and imaging data for research using artificial intelligence and radiomics to predict hepatocellular carcinoma risk in cirrhosis patients. The effort aims to develop predictive models that improve cancer risk assessment and recurrence evaluation, supporting translational liver disease research.